Clinical Trials Browser

Suspended × OTHER × Nivolumab × Clear all

NCT07011550 2026-03-11

Phase 2, Single-arm Trial of BMS-986340 in Association With Nivolumab, Trifluridine/Tipiracil and Bevacizumab for Patients Refractory to Standard of Care Treatment and With Microsatellite-stable Colorectal Cancer

Phase 2 Suspended

Gastrointestinal

Microsatellite-stable Colorectal Cancer

NCT05928806 2026-02-11

ARCITECT

Phase 2 Suspended

Advanced Renal Cell Carcinoma

NCT06049576 2025-12-17

Nivolumab and Ipilimumab With and Without Camu Camu for the Treatment of Patients With Metastatic Renal Cell Carcinoma

Phase 1 Suspended

Carcinoma, Renal Cell

NCT05445609 2025-09-19

Vidutolimod (CMP-001) in Combination With Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer

Phase 2 Suspended

Prostatic Neoplasms

NCT04268888 2025-02-26

TACE-3

Phase 2/3 Suspended

Gastrointestinal

Carcinoma, Hepatocellular